Related Experiment Video
Updated: Aug 14, 2026
Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
Published on: November 29, 2013
Effects of dietary oils on the development of gastric ulcers in mares
Nicholas Frank1, Frank M Andrews, Sarah B Elliott
1Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville 37996, USA.
Objective:
To assess antiulcerogenic properties of 3 dietary oils.
Animals:
8 healthy adult mares.
Procedure:
A protocol to induce gastric ulcers was used and included 240 mL of water plus corn oil, refined rice bran oil, or crude rice bran oil administered each day for 6 weeks according to a 4 x 4 Latin square randomized crossover design with 5-week washout intervals. A 7-day alternating feed deprivation period was included between weeks 5 and 6. Omeprazole was administered daily for the last 14 days of each washout interval. Endoscopic examinations of the stomach were performed at 0, 5, and 6 weeks, and the number (0 to 4 scale) and severity (0 to 5 scale) of ulcers were scored. Gastric fluid was collected at 0 and 5 weeks.
Results:
Median body weight significantly increased by 29 kg (range, 10 to 50 kg). Mean +/- SE gastric fluid pH significantly decreased from 4.9 +/- 0.4 to 3.1 +/- 0.3 over 5 weeks, and total volatile fatty acid concentration significantly decreased over time. Mean +/- SE severity of nonglandular ulcers significantly increased from 0.4 +/- 0.1 to 1.2 +/- 0.2 over 5 weeks. Nonglandular ulcers significantly increased in number (mean +/- SE, 1.3 +/- 0.2 to 3.0 +/- 0.2) and severity (mean +/- SE, 1.2 +/- 0.2 to 2.6 +/- 0.2) during the 7-day alternating feed deprivation period. No effects of treatment were detected.
Conclusions And Clinical Relevance:
In this model dietary oils did not prevent gastric ulcers from forming in the nonglandular portion of the stomach of horses.
Related Concept Videos
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...